The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Fuel Cell Catalyst Patent

21 Dec 2012 07:00

RNS Number : 0918U
Ilika plc
21 December 2012
 



 

Ilika plc

("Ilika" or the "Company")

 

Grant of Fuel Cell Catalyst Patent

 

Ilika (AIM: IKA), the advanced cleantech materials company, announces that it has received notification that its patent application covering the use of lower cost metal alloys as electro-catalysts in PEM fuel cells has been granted in the USA.

 

In a fuel cell, a controlled reaction occurs between hydrogen and oxygen. This reaction requires electro-catalysts, which are currently based on the precious metal, platinum. Ilika has developed a novel platinum-free catalyst, which, on a cost/performance basis, has been shown to be 70% cheaper than the current industry standard. The electro-catalysts, which were originally discovered using Ilika's high throughput materials development platform at its facility in Southampton, UK, have been subsequently manufactured to Ilika's specification by a partner using an industrially-scalable process.

 

The grant of this patent is therefore a significant step forward in securing the intellectual property in the major markets in which Ilika intends to commercialize its proprietary technology. Further grants of the patent family in other jurisdictions around the world are expected in 2013.

 

As communicated in Ilika's Trading update released in October 2012, Ilika's lead automotive partner has commenced its assessment of the technical performance of Ilika's proprietary fuel cell catalysts. Initial samples are being made available for confirmatory testing prior to designing a larger scale programme. A larger batch of electro-catalyst is currently being manufactured to Ilika's specification for delivery in the first half of CY 2013.

 

This patent underpins the product development work, which is being supported by the Carbon Trust through the £150,000 equity investment Ilika announced in September 2012. The Carbon Trust invested in Ilika through its Polymer Fuel Cells Challenge programme, to support the commercialization of Ilika's high performing electro-catalysts for use in fuel cell vehicles. As part of the Carbon Trust's technical and commercial evaluation of the technology, Ilika submitted performance data for assessment by independent experts demonstrating the performance and stability of the catalyst. The performance data was generated in industry standard tests of membrane electrode assemblies (MEA's) carried out at an independent fuel cell testing facility. The investment from the Carbon Trust is currently supporting Ilika in having a larger quantity of the electro-catalyst made for testing by the major automotive OEMs that have expressed their interest in the technology.

 

Graeme Purdy, Chief Executive of Ilika, added: "The grant of this patent by the USPTO confirms the novelty and inventiveness of Ilika's intellectual property in this area. The Ilika team is very focussed on ensuring the successful commercialisation of this technology with our key partners".

 

 

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or paul.cornelius@walbrookir.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEFEESFESEIE
Date   Source Headline
14th Aug 20203:56 pmRNSHolding(s) in Company
14th Aug 20202:06 pmRNSSecond Price Monitoring Extn
14th Aug 20202:01 pmRNSPrice Monitoring Extension
24th Jul 20202:06 pmRNSSecond Price Monitoring Extn
24th Jul 20202:01 pmRNSPrice Monitoring Extension
17th Jul 20202:06 pmRNSSecond Price Monitoring Extn
17th Jul 20202:00 pmRNSPrice Monitoring Extension
17th Jul 202011:06 amRNSSecond Price Monitoring Extn
17th Jul 202011:02 amRNSPrice Monitoring Extension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:37 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSFinal Results
16th Jun 20207:00 amRNSCOVID-19 Update, Facility Re-opening
10th Jun 20204:14 pmRNSHolding(s) in Company
10th Jun 202011:05 amRNSSecond Price Monitoring Extn
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSTrading Update & Notice of Results
8th Jun 20204:42 pmRNSSecond Price Monitoring Extn
8th Jun 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSAppointment of Non-Executive Director
20th Apr 20207:00 amRNSCEO appointed as NED of Bacanora Lithium plc
6th Apr 20207:00 amRNSInvestor presentation
30th Mar 20204:25 pmRNSHolding(s) in Company
30th Mar 20202:40 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 202010:58 amRNSHolding(s) in Company
27th Mar 20209:00 amRNSAward of Share Options, Exercise of Options & TVR
25th Mar 20201:45 pmRNSResults of General Meeting and Open Offer & TVR
25th Mar 202011:06 amRNSSecond Price Monitoring Extn
25th Mar 202011:01 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSCOVID-19 Update
19th Mar 20204:15 pmRNSGeneral Meeting: Change of Venue
18th Mar 202011:07 amRNSSecond Price Monitoring Extn
18th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20205:20 pmRNSResult of Placing
6th Mar 20201:20 pmRNSProposed Placing & Open Offer
7th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
4th Feb 20207:00 amRNSSuccessful Stereax Field Trial
23rd Jan 20207:00 amRNSHalf-year Report
15th Jan 202011:06 amRNSSecond Price Monitoring Extn
15th Jan 202011:01 amRNSPrice Monitoring Extension
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
13th Jan 202011:08 amRNSSecond Price Monitoring Extn
13th Jan 202011:05 amRNSPrice Monitoring Extension
10th Jan 20202:07 pmRNSSecond Price Monitoring Extn
10th Jan 20202:01 pmRNSPrice Monitoring Extension
2nd Jan 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jan 20204:37 pmRNSPrice Monitoring Extension
19th Dec 20194:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.